Unknown

Dataset Information

0

Effect of epigenetic treatment on SST2 expression in neuroendocrine tumour patients.

ABSTRACT:

SUBMITTER: Refardt J 

PROVIDER: S-EPMC9304941 | biostudies-literature | 2022 Jul

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Effect of epigenetic treatment on SST<sub>2</sub> expression in neuroendocrine tumour patients.

Refardt Julie J   Klomp Maria J MJ   van Koetsveld Peter M PM   Dogan Fadime F   Konijnenberg Mark M   Brabander Tessa T   Feelders Richard A RA   de Herder Wouter W WW   Hofland Leo J LJ   Hofland Johannes J  

Clinical and translational medicine 20220701 7

Similar Datasets

Unknown Epigenetic regulation of SST<sub>2</sub> expression in small intestinal neuroendocrine tumors.
| S-EPMC10200989 | biostudies-literature
Unknown Prognostic factors and treatment impact on overall survival in patients with renal neuroendocrine tumour.
| S-EPMC11168774 | biostudies-literature
Unknown Expression of somatostatin receptors 2 and 5 in circulating tumour cells from patients with neuroendocrine tumours.
| S-EPMC5155369 | biostudies-literature
Unknown Epigenetic landscape of pancreatic neuroendocrine tumours reveals distinct cells of origin and means of tumour progression.
| S-EPMC7721725 | biostudies-literature
Unknown Dimerization of GPCRs: Novel insight into the role of FLNA and SSAs regulating SST<sub>2</sub> and SST<sub>5</sub> homo- and hetero-dimer formation.
| S-EPMC9389162 | biostudies-literature
Unknown Comparison of the Anti-Tumour Activity of the Somatostatin Receptor (SST) Antagonist [<sup>177</sup>Lu]Lu-Satoreotide Tetraxetan and the Agonist [<sup>177</sup>Lu]Lu-DOTA-TATE in Mice Bearing AR42J SST<sub>2</sub>-Positive Tumours.
| S-EPMC9506113 | biostudies-literature
Unknown Effect of Octreotide Long-Acting Release on Tregs and MDSC Cells in Neuroendocrine Tumour Patients: A Pivotal Prospective Study.
| S-EPMC7563951 | biostudies-literature
Unknown Octreotide and Pasireotide Combination Treatment in Somatotroph Tumor Cells: Predominant Role of SST<sub>2</sub> in Mediating Ligand Effects.
| S-EPMC8069349 | biostudies-literature
Unknown Treatment of appendiceal neuroendocrine tumour: a controversial treatment for a misunderstood neoplasm in a mysterious organ.
| S-EPMC11385537 | biostudies-literature
Unknown EZH2 Inhibition as New Epigenetic Treatment Option for Pancreatic Neuroendocrine Neoplasms (PanNENs).
| S-EPMC8508156 | biostudies-literature